Quadruple Screening in the Age of Cell-Free DNA: What are We Losing?

Are we losing our edge?

Gabriel Aeppli was born in Switzerland, but when he was 1 year old, his father came to the U.S. to pursue a career as a mathematician. Back then, America was a scientific "city on the hill," a place where enormous resources, academic freedom, a tradition of skepticism and a history of excellence lured everyone from astronomers to zoologists from all over the world, and like Aeppli's father, man...

Newborn hearing screening: what are we missing?

The objectives of the study were to demonstrate hearing status in newborns at first screening by Transient Evoked Otoacoustic Emissions and to find out the relationship between abnormal hearing screening and known risk factors. This study was conducted in the department of neonatology of Bangabandhu Sheikh Mujib Medical University in collaboration with department of otolaryngology and departmen...

Spamming Botnets: Are we losing the war?∗

In this work, we examine the spamming activity of the IP space over time, and observe a worrisome phenomenon: spamming botnets are more widely and thinly spread in the IP space over the last four years. We find that (a), a previouslyunreported IP space (113.* 126.*) has become a major source of spamming activity, and (b), the spamming activity is more equally distributed among IP addresses. Thi...

Are we losing the war on cancer?

Clinicians and scientists in the 21st century in the modern era of cancer care see many great advances moving from the lab to the clinic with demonstrated impact on overall survival of patients with cancer thereby gaining approval and widespread use. Examples of modern miracles include the targeted agents imatinib, erlotinib, rituximab, herceptin, cetuximab, panitumumab, bevacizumab, sorafenib,...

Are we losing the TB battle?